Dedicated neck 18 F-FDG PET/CT: An additional tool for risk assessment in thyroid nodules at ultrasound intermediate risk.
Pierpaolo TrimboliArnoldo PiccardoMaria AlevizakiCamilla ViriliMehrdad NaseriSimona SolaGaetano PaoneGilles RussLuca M GiovanellaPublished in: Clinical endocrinology (2019)
18 F-FDG PET/CT may have a role in stratifying the cancer risk of thyroid nodules with an intermediate ultrasound assessment. More specifically, thyroid lesions classified as EU-TIRADS 4 and with no 18 F-FDG uptake could be ruled out from further examination, similar to other anamnestic and clinical suspicious factors of patients. Further prospective and cost-effectiveness studies are needed.
Keyphrases
- risk assessment
- end stage renal disease
- magnetic resonance imaging
- ejection fraction
- newly diagnosed
- chronic kidney disease
- papillary thyroid
- prognostic factors
- peritoneal dialysis
- pet ct
- squamous cell carcinoma
- ultrasound guided
- human health
- squamous cell
- contrast enhanced ultrasound
- patient reported outcomes
- lymph node metastasis